Sarah N McCurdy

Title: Innovations of Sarah N McCurdy

Introduction

Sarah N McCurdy is a prominent inventor based in San Mateo, California. She has made significant contributions to the field of biotechnology, particularly in the area of sequence analysis. With a total of four patents to her name, McCurdy's work has advanced the understanding and application of genetic analysis techniques.

Latest Patents

One of her latest patents focuses on an improvement in adaptor-based sequence analysis. This innovation addresses the challenges posed by the self-ligation of target polynucleotides that have complementary ends. The improvement involves the preparation of target polynucleotides with dephosphorylated 5' strands and the use of adaptors that contain a 3' blocking group. In a preferred embodiment, adaptors are ligated to target polynucleotides by a single strand. The 3' blocking groups are then removed, allowing the adjacent 5' hydroxyl of the target polynucleotide to be phosphorylated. The ligation of the adaptor is completed through treatment with a ligase.

Career Highlights

Sarah N McCurdy is currently associated with Lynx Therapeutics, Inc., where she continues to innovate in the field of genetic research. Her work has been instrumental in developing more efficient methods for sequence analysis, which are crucial for advancements in genomics and molecular biology.

Collaborations

Throughout her career, McCurdy has collaborated with notable professionals in her field, including Sergei M Gryaznov and Robert B Dubridge. These collaborations have further enriched her research and contributed to the success of her innovations.

Conclusion

Sarah N McCurdy's contributions to biotechnology and her innovative patents in sequence analysis highlight her role as a leading inventor in her field. Her work continues to influence advancements in genetic research and analysis techniques.